HIV-1 viral load assays for resource-limited settings.
Fiscus
Susan A
SA
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. fiscussa@med.unc.edu
Cheng
Ben
B
Crowe
Suzanne M
SM
Demeter
Lisa
L
Jennings
Cheryl
C
Miller
Veronica
V
Respess
Richard
R
Stevens
Wendy
W
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D019049:Developed Countries / Q000191:economics; D003906:Developing Countries / Q000191:economics*; D004797:Enzyme-Linked Immunosorbent Assay / Q000191:economics; D005260:Female; D016655:HIV Core Protein p24 / Q000097:blood; D015658:HIV Infections / Q000175:diagnosis / Q000201:enzymology / Q000276:immunology / Q000635:transmission / Q000821:virology*; D054303:HIV Reverse Transcriptase / Q000097:blood; D015497:HIV-1 / Q000201:enzymology / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D016133:Polymerase Chain Reaction / Q000191:economics / Q000379:methods; D011247:Pregnancy; D012367:RNA, Viral / Q000097:blood*; D011933:Reagent Kits, Diagnostic / Q000191:economics*; D012680:Sensitivity and Specificity; D013048:Specimen Handling; D016896:Treatment Outcome; D019562:Viral Load
D044966:Anti-Retroviral Agents; D016655:HIV Core Protein p24; D012367:RNA, Viral; D011933:Reagent Kits, Diagnostic; D054303:HIV Reverse Transcriptase